Drug Target Review2025-07-29T14:00:59
Effective financial management is vital for clinical trial success, yet many preclinical and clinical companies face inefficiencies due to outdated systems. Jennifer Kyle, CEO of Condor Software, explains how advanced financial platforms can streamline processes, improve forecasting and ensure better resource allocation throughout drug development.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2024-03-08T10:00:25
Sponsored by Molecular Devices
2026-06-01T07:00:00
Contributor Dr Timothy O’Connor, Drug Target Review
2026-09-23T15:00:00
Sponsored by BioIVT
2023-02-07T15:25:20
Sponsored by Bio-Techne
2026-07-23T06:20:00
Contributor Laura Lotfi, Drug Target Review
2026-07-31T06:00:00
Contributor Dr Davinder Ramsingh, Drug Target Review
Site powered by Webvision Cloud